BioSpace News Archive

ARIKAYCE Preliminary U.S. Net Product Sales Approximately $21.0 Million for the First Quarter of 2019

Metrion Biosciences, the specialist ion channel contract research and drug discovery company, announced the appointment of Dr Andrew Southan as Chief Executive Officer, with immediate effect.

Alnylam to Advance Selected Investigational Asset in an Undisclosed Rare Genetic Disease Through the End of IND-Enabling Studies

CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company to European investors, Monday, April 8, 2019, at the H.C. Wainwright Global Life Sciences Conference 2019 in London, England.

Merger combines more than 30 years of patient-centered expertise to Empower Everyone, Ignore No One

United Therapeutics Corporation announced that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of delayed time to first clinical worsening event.

Axonics Modulation Technologies, Inc. announced that Nancy L. Snyderman, M.D. and Jane E. Kiernan have been appointed to the Axonics board of directors, effective immediately.

ACell, Inc. announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd.

[08-April-2019] NORTH HOLLYWOOD, Calif. , April 8, 2019 /PRNewswire/ -- ConsejoSano , a multicultural patient engagement platform for payers, providers and health systems, announced today that Dr. Molly J. Coye has joined ConsejoSano’s board of directors. Dr. Coye brings over 40 years of expertise in identifying and deploying innovation across large scale patient populations. She has previo

Singer/Songwriter, David Crosby will participate in the 2019 WeedCon Cup competition as judge and presenter supporting the United States’ premier cannabis cup competition awarding excellence for cannabis products.